PATENT CLAIM ANALYSIS

Application Number: 16001310
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene to induce exon 53 skipping are described.

Claim (Index 6):
An antisense oligomer conjugate of Formula (II): or a pharmaceutically acceptable salt thereof, wherein each Nu from 1 to 25 and 5\u2032 to 3\u2032 is: Position No. 5\u2032 to 3\u2032 Nu 1 G 2 X 3 X 4 G 5 C 6 C 7 X 8 C 9 C 10 G 11 G 12 X 13 X 14 C 15 X 16 G 17 A 18 A 19 G 20 G 21 X 22 G 23 X 24 X 25 C and wherein A is and each X is independently

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13219401', '15735094', '14214567', '15466631', '15085801']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7090990817812352
- 35 USC 102 Novelty (BERT): 0.5642826501414498
- Combined Prediction Score: 0.6946174386172567
- Mean Citation Score: 464.86123000000015
- Max Citation Score: 502.396
- Similarity Product: 284.19400537252426

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test